Company Valuation: China Biotech Services Holdings Limited

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 1,256 1,329 1,108 741.7 497.6 770.8
Change - 5.84% -16.67% -33.04% -32.91% 54.9%
Enterprise Value (EV) 1 976.4 1,244 1,097 770 666.5 1,154
Change - 27.42% -11.85% -29.79% -13.44% 73.08%
P/E 41.7x 68.7x 4.29x -7.77x -2.49x -11.2x
PBR 3.66x 3.36x 1.84x 1.6x 1.88x 4.03x
PEG - -1.9x 0x 0x -0x 0.2x
Capitalization / Revenue 1.92x 2.13x 0.6x 3.5x 7.06x 10.5x
EV / Revenue 1.49x 1.99x 0.59x 3.63x 9.45x 15.7x
EV / EBITDA 4.34x 5.08x 1.22x -10.7x -5.05x -18.2x
EV / EBIT 5x 6.56x 1.3x -6.59x -4.56x -15.6x
EV / FCF 3.88x 49.2x 5.83x 14.3x -183x -7.19x
FCF Yield 25.7% 2.03% 17.1% 7% -0.55% -13.9%
Dividend per Share 2 - - 0.01 - - -
Rate of return - - 0.87% - - -
EPS 2 0.0312 0.0201 0.2679 -0.0991 -0.2046 -0.0705
Distribution rate - - 3.73% - - -
Net sales 1 655.8 623.8 1,852 212 70.51 73.5
EBITDA 1 224.9 245 900.8 -72.16 -132.1 -63.47
EBIT 1 195.3 189.5 845.1 -116.9 -146.3 -73.86
Net income 1 30.17 19.38 258.1 -95.45 -198.1 -68.78
Net Debt 1 -279.5 -85.14 -10.99 28.31 168.9 382.8
Reference price 2 1.3000 1.3800 1.1500 0.7700 0.5100 0.7900
Nbr of stocks (in thousands) 966,046 963,231 963,231 963,231 975,731 975,731
Announcement Date 3/29/21 3/31/22 3/29/23 4/1/24 4/23/25 4/29/26
1HKD in Million2HKD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 61.59M
13.6x0.41x8.58x2.85% 120B
15.82x1.93x9.64x0.66% 102B
-281.44x19.63x-331.94x-.--% 58.23B
13.97x1.53x9.26x2.53% 29.08B
23.47x2.62x13.27x1.37% 26.7B
23.61x2.16x12.37x0.89% 26.68B
8.15x1.46x6.61x-.--% 21.62B
28.71x5.25x21.8x2.43% 19.58B
20.23x1.81x9.1x3.51% 18.93B
Average -14.88x 4.09x -26.81x 1.58% 42.19B
Weighted average by Cap. -24.58x 4.10x -37.04x 1.55%

Y-o-Y evolution of P/E

Valuation ratios - P/E - China Biotech Services Holdings Limited

Historical PBR trend

Valuation ratios - PBR - China Biotech Services Holdings Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - China Biotech Services Holdings Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - China Biotech Services Holdings Limited

  1. Stock Market
  2. Stocks
  3. 8037 Stock
  4. Valuation China Biotech Services Holdings Limited